NewLimit, a health company founded by Coinbase's founder, has completed a $130 million Series B financing.

ForesightNews

Foresight News reports that, according to Fortune magazine, NewLimit, an anti-aging startup founded by Coinbase founder Brian Armstrong, has completed a $130 million Series B financing round, led by Kleiner Perkins, with participation from Khosla Ventures and Founders Fund. Brian Armstrong stated that NewLimit’s research is based on a relatively new scientific field—epigenetic reprogramming, which can manipulate cells to restore them to a younger or healthier state.

View Original
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments